Review Articles
FcRn Inhibition As a Therapeutic Class
FcRn inhibitors in IgG autoimmune disease: targeted therapy transforming treatment of gMG and CIDP with ...
JULY 18, 2026
Managing Tardive Dyskinesia: Drug-Induced Risks and Therapeutic Advances
Tardive dyskinesia treatment overview: causes, risk factors, prevention, and VMAT2 inhibitor therapy for improved ...
JULY 6, 2026
Emerging Therapies For Blood Cancers
Blood cancers 2025–2026: new AML, MCL, MM, and lymphoma therapies, including menin inhibitors and updated ...
JULY 3, 2026
Top 10 Patient Safety Concerns of 2025: A Pharmacy-Focused Review
Patient safety 2025: Explore ECRI and ISMP’s Top 10 safety concerns and how pharmacists can lead efforts to ...
JUNE 29, 2026
Rebuilding the Hazardous Drug List:
NIOSH hazardous drug list 2024 update: Experts propose AI and cross-industry solutions to strengthen safe handling ...
JUNE 28, 2026
Microbial Identification In Sterile Compounding
Microbial identification in sterile compounding: ensure USP ?<797> compliance, accurate testing, and ...
JUNE 13, 2026
Clinical Characterization and Multimodal Management Of Pediatric Acute-Onset Neuropsychiatric Syndrome
Pediatric acute-onset neuropsychiatric syndrome overview of diagnosis, clinical features, and multidisciplinary ...
MAY 31, 2026
Top 10 Patient Safety Concerns of 2025: A Pharmacy-Focused Review
Every clinician enters practice with a commitment to "do no harm," yet preventable harm occurs daily in healthcare ...
MAY 4, 2026
The Role of Intravenous Immunoglobulin Therapy in Dermatomyositis
IVIG in dermatomyositis: evidence-based therapy, safety measures, and strategies to reduce thromboembolic risk for ...
APRIL 1, 2026
Parenteral Nutrition Therapy: Assessment Tools and Guidelines
Parenteral nutrition therapy guidelines for assessing malnutrition, initiating EN or PN, and ensuring safe, ...
MARCH 3, 2026
Medication Errors: Year in Review
Drug safety initiatives highlight strategies to reduce risks, strengthen systems, and enhance patient protection in ...
FEBRUARY 4, 2026
Myth-Busters:
Postexposure care guidance dispels false beliefs and reinforces correct rabies prophylaxis practices.
JANUARY 29, 2026
